BIO-key International (BKYI) said it received a notification letter from Nasdaq for failing to timely file its quarterly report on Form 10-Q for the period ended March 31, 2026, putting it in breach of Nasdaq Listing Rule 5250(c)(1).
Nasdaq said its Hearing Panel will consider the matter in determining whether the company's shares will remain listed on the Nasdaq Capital Market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments